Free Trial

Amprius Technologies (AMPX) Financials

Amprius Technologies logo
$16.83 +0.52 (+3.18%)
Closing price 06/15/2026 03:59 PM Eastern
Extended Trading
$16.82 0.00 (-0.02%)
As of 06/15/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Amprius Technologies

Annual Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)
-9.90 -17 -37 -45 -44
Net Income / (Loss) Continuing Operations
-9.90 -17 -37 -45 -44
Total Pre-Tax Income
-9.90 -17 -37 -45 -44
Total Operating Income
-11 -18 -39 -46 -47
Total Gross Profit
-4.33 -5.65 -15 -18 8.26
Total Revenue
2.77 4.41 9.05 24 73
Operating Revenue
2.77 4.41 9.05 24 73
Total Cost of Revenue
7.10 10 24 42 65
Operating Cost of Revenue
7.10 10 24 42 65
Total Operating Expenses
6.29 12 24 28 55
Selling, General & Admin Expense
4.84 10 20 19 23
Research & Development Expense
1.45 2.03 3.68 7.34 9.43
Restructuring Charge
- - - 1.86 23
Total Other Income / (Expense), net
0.73 0.71 1.93 1.59 2.62
Interest & Investment Income
-0.02 0.71 2.51 1.59 2.62
Basic Earnings per Share
($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Basic Shares Outstanding
65.76M 71.34M 86.20M 101.87M 124.64M
Diluted Earnings per Share
($0.15) ($0.24) ($0.43) ($0.45) ($0.35)
Weighted Average Diluted Shares Outstanding
65.76M 71.34M 86.20M 101.87M 124.64M
Weighted Average Basic & Diluted Shares Outstanding
- 84.63M 91.60M 117.93M 137.02M

Quarterly Income Statements for Amprius Technologies

This table shows Amprius Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
-8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Consolidated Net Income / (Loss)
-8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Net Income / (Loss) Continuing Operations
-8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Total Pre-Tax Income
-8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Total Operating Income
-9.13 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25 -6.69
Total Gross Profit
-4.25 -3.88 -4.45 -6.53 -5.10 -2.25 -2.36 1.34 3.32 5.97 5.74
Total Revenue
2.80 3.94 2.34 3.35 7.86 11 11 15 21 25 29
Operating Revenue
2.80 3.94 2.34 3.35 7.86 11 11 15 21 25 29
Total Cost of Revenue
7.05 7.82 6.78 9.88 13 13 14 14 18 19 23
Operating Cost of Revenue
7.05 7.82 6.78 9.88 13 13 14 14 18 19 23
Total Operating Expenses
4.88 5.87 5.87 6.40 6.15 9.51 7.31 8.15 8.01 31 12
Selling, General & Admin Expense
4.07 4.58 4.29 4.74 4.34 5.36 5.31 5.99 5.50 6.16 8.63
Research & Development Expense
0.82 1.29 1.58 1.66 1.82 2.28 2.00 2.16 2.51 2.76 3.80
Total Other Income / (Expense), net
0.64 0.01 0.43 0.42 0.40 0.34 0.30 0.44 0.80 1.08 1.64
Basic Earnings per Share
($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Weighted Average Basic Shares Outstanding
86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Diluted Earnings per Share
($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Weighted Average Diluted Shares Outstanding
86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Weighted Average Basic & Diluted Shares Outstanding
88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M 141.63M

Annual Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
11 58 -24 11 36
Net Cash From Operating Activities
-8.02 -14 -26 -33 -31
Net Cash From Continuing Operating Activities
-8.02 -14 -26 -33 -31
Net Income / (Loss) Continuing Operations
-9.90 -17 -37 -45 -44
Consolidated Net Income / (Loss)
-9.90 -17 -37 -45 -44
Depreciation Expense
1.44 1.54 1.81 3.81 4.37
Amortization Expense
0.55 1.59 3.06 6.39 5.14
Non-Cash Adjustments To Reconcile Net Income
1.89 3.27 5.61 9.21 30
Changes in Operating Assets and Liabilities, net
-2.00 -2.94 0.75 -8.08 -27
Net Cash From Investing Activities
-0.61 -1.48 -18 -3.21 -4.40
Net Cash From Continuing Investing Activities
-0.61 -1.48 -18 -3.21 -4.40
Purchase of Property, Plant & Equipment
-0.61 -1.48 -18 -3.21 -4.40
Net Cash From Financing Activities
20 74 19 47 71
Net Cash From Continuing Financing Activities
20 74 19 47 71
Repurchase of Common Equity
0.00 -0.33 -0.60 -0.76 0.00
Issuance of Common Equity
0.00 78 19 33 64
Other Financing Activities, net
20 -3.93 0.31 14 7.37
Effect of Exchange Rate Changes
- - - 0.00 0.00

Quarterly Cash Flow Statements for Amprius Technologies

This table details how cash moves in and out of Amprius Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
-12 -7.64 -5.52 7.40 -11 20 -6.53 5.78 19 17 -29
Net Cash From Operating Activities
-8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50 -37
Net Cash From Continuing Operating Activities
-8.68 -4.80 -9.78 -7.96 -9.53 -6.09 -14 -4.27 -9.25 -3.50 -37
Net Income / (Loss) Continuing Operations
-8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Consolidated Net Income / (Loss)
-8.49 -9.73 -9.89 -13 -11 -11 -9.37 -6.37 -3.89 -24 -5.05
Depreciation Expense
0.46 0.49 1.02 1.04 0.86 0.89 0.94 1.02 1.18 1.22 0.76
Amortization Expense
1.48 1.18 1.29 - 5.10 1.29 1.29 1.29 1.29 1.29 0.62
Non-Cash Adjustments To Reconcile Net Income
0.61 2.84 1.25 3.23 -0.85 4.30 2.10 2.45 1.39 24 1.76
Changes in Operating Assets and Liabilities, net
-2.74 0.43 -3.44 0.30 -3.80 -1.14 -9.08 -2.65 -9.21 -6.07 -36
Net Cash From Investing Activities
-8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.63
Net Cash From Continuing Investing Activities
-8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.63
Purchase of Property, Plant & Equipment
-8.93 -5.75 -3.90 -1.61 -1.33 3.63 -0.91 -0.72 -0.41 -2.36 -0.98
Sale of Property, Plant & Equipment
- - - - - - 0.00 - - - 0.36
Net Cash From Financing Activities
6.00 2.92 8.16 17 -0.54 23 8.51 11 29 23 8.58
Net Cash From Continuing Financing Activities
6.00 2.92 8.16 17 -0.54 23 8.51 11 29 23 8.58
Issuance of Common Equity
6.04 2.92 8.13 2.73 - 23 8.46 9.74 26 20 0.00
Other Financing Activities, net
0.11 0.20 0.03 14 - 0.01 0.05 1.02 2.83 3.47 8.58
Effect of Exchange Rate Changes
- - 0.00 - - - -0.00 -0.00 0.00 0.01 0.01

Annual Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
19 83 108 121 157
Total Current Assets
14 75 51 69 126
Cash & Equivalents
11 70 46 55 90
Accounts Receivable
0.26 0.69 1.27 5.58 24
Inventories, net
0.50 0.50 0.73 6.57 6.74
Prepaid Expenses
0.16 2.39 1.99 1.45 5.50
Plant, Property, & Equipment, net
4.21 4.24 22 17 9.68
Total Noncurrent Assets
0.14 3.76 35 35 21
Other Noncurrent Operating Assets
0.14 3.76 35 35 21
Total Liabilities & Shareholders' Equity
19 83 108 121 157
Total Liabilities
4.67 10 48 52 53
Total Current Liabilities
4.17 6.92 13 17 18
Accounts Payable
1.81 3.74 8.94 12 10
Current Deferred Revenue
2.36 2.66 3.43 1.64 2.84
Other Current Liabilities
0.00 0.52 1.09 3.32 4.67
Total Noncurrent Liabilities
0.50 3.22 34 34 35
Other Noncurrent Operating Liabilities
0.00 2.50 34 34 35
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
14 73 60 69 104
Total Preferred & Common Equity
14 73 60 69 104
Preferred Stock
- 0.00 0.00 0.00 0.00
Total Common Equity
14 73 60 69 104
Common Stock
89 166 189 244 322
Retained Earnings
-75 -93 -130 -174 -218
Accumulated Other Comprehensive Income / (Loss)
- - - 0.00 0.00

Quarterly Balance Sheets for Amprius Technologies

This table presents Amprius Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
87 84 87 87 105 113 104 118 123 156 131
Total Current Assets
78 70 71 61 46 53 45 66 72 107 114
Cash & Equivalents
74 64 65 53 39 46 35 48 54 73 62
Accounts Receivable
0.78 0.56 1.13 1.89 1.44 1.74 4.59 10 11 22 35
Inventories, net
0.50 0.85 0.50 0.49 0.86 1.53 2.66 4.00 4.34 4.68 8.25
Prepaid Expenses
2.32 1.84 1.48 2.74 3.35 2.17 2.64 3.31 2.56 6.88 8.10
Plant, Property, & Equipment, net
3.82 4.95 6.90 17 23 24 24 18 17 16 11
Total Noncurrent Assets
4.86 9.10 9.03 8.55 36 36 35 34 34 33 6.08
Other Noncurrent Operating Assets
4.86 9.10 9.03 8.55 36 36 35 34 34 33 6.08
Total Liabilities & Shareholders' Equity
87 84 87 87 105 113 104 118 123 156 131
Total Liabilities
11 17 20 21 45 48 48 48 46 53 21
Total Current Liabilities
6.14 8.88 12 14 9.76 13 13 14 12 16 16
Accounts Payable
4.82 4.69 7.74 9.23 5.42 7.76 9.13 8.55 7.81 12 12
Current Deferred Revenue
0.80 3.14 3.20 3.57 3.24 3.15 1.82 1.78 0.84 0.71 2.76
Other Current Liabilities
0.52 1.06 1.07 1.08 1.10 1.92 2.05 3.64 3.43 3.22 1.17
Total Noncurrent Liabilities
4.36 8.03 7.94 6.98 35 35 35 34 34 37 5.39
Other Noncurrent Operating Liabilities
2.58 7.13 7.00 6.87 35 35 35 34 34 37 5.39
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
76 67 67 66 60 65 56 70 77 103 109
Total Preferred & Common Equity
76 67 67 66 60 65 56 70 77 103 109
Preferred Stock
- - 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
76 67 67 66 60 65 56 70 77 103 109
Common Stock
163 169 178 186 199 217 219 254 267 297 333
Retained Earnings
-87 -102 -111 -120 -140 -152 -163 -184 -190 -194 -223
Accumulated Other Comprehensive Income / (Loss)
- - - - - - - -0.00 -0.01 -0.00 0.01

Annual Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric 2021 2022 2023 2024 2025
Period end date 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
- - - - 130,483,838.00
DEI Adjusted Shares Outstanding
- - - - 130,483,838.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - -0.34
Growth Metrics
- - - - -
Profitability Metrics
- - - - -
Net Operating Profit after Tax (NOPAT)
-7.44 -13 -27 -32 -33
Return On Investment Capital (ROIC_SIMPLE)
- - -45.31% -46.61% -31.45%
Earnings before Interest and Taxes (EBIT)
-11 -18 -39 -46 -47
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-8.63 -15 -34 -36 -37
Valuation Ratios
- - - - -
Leverage & Solvency
- - - - -
Liquidity Ratios
- - - - -
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 -14 -38 -33 -32
Efficiency Ratios
- - - - -
Capital & Investment Metrics
- - - - -
Invested Capital
2.37 3.34 14 14 13
Increase / (Decrease) in Invested Capital
0.00 0.97 11 0.28 -0.97
Book Value per Share
$0.21 $0.86 $0.68 $0.66 $0.80
Tangible Book Value per Share
$0.21 $0.86 $0.68 $0.66 $0.80
Total Capital
14 73 60 69 104
Total Debt
0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00
Net Debt
-11 -70 -46 -55 -90
Capital Expenditures (CapEx)
0.61 1.48 18 3.21 4.40
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-1.48 -1.44 -8.70 -3.60 18
Debt-free Net Working Capital (DFNWC)
10 68 37 52 109
Net Working Capital (NWC)
10 68 37 52 109
Net Nonoperating Expense (NNE)
2.46 4.70 9.68 12 11
Net Nonoperating Obligations (NNO)
-11 -70 -46 -55 -90
Total Depreciation and Amortization (D&A)
1.99 3.12 4.86 10 9.51
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Basic Shares Outstanding
0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Diluted Earnings per Share
$0.00 ($0.24) ($0.43) ($0.45) ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 71.34M 86.20M 101.87M 124.64M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 84.63M 91.60M 117.93M 137.02M
Normalized Net Operating Profit after Tax (NOPAT)
-7.44 -13 -27 -31 -17
Debt Service Ratios
- - - - -
Payout Ratios
- - - - -

Quarterly Metrics And Ratios for Amprius Technologies

This table displays calculated financial ratios and metrics derived from Amprius Technologies' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - 130,483,838.00 137,019,004.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 130,483,838.00 137,019,004.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - -0.19 -0.04
Growth Metrics
- - - - - - - - - - -
Revenue Growth
242.89% 397.98% 244.04% 104.96% 180.74% 169.55% 383.05% 350.43% 172.77% - 152.89%
EBITDA Growth
-99.83% -29.32% -3.37% -24.21% 26.48% -18.58% 7.16% 57.50% 81.01% - 28.69%
EBIT Growth
-111.22% -46.59% -5.83% -28.26% -23.24% -20.67% 6.28% 47.32% 58.30% - 30.86%
NOPAT Growth
-111.22% -46.59% -5.83% -28.26% -23.24% -20.67% 6.28% 47.32% 58.30% - 30.86%
Net Income Growth
-100.09% -60.73% -8.61% -32.48% -27.77% -17.30% 5.21% 49.11% 64.13% - 46.15%
EPS Growth
-66.67% -37.50% 0.00% -18.18% 0.00% 0.00% 27.27% 61.54% 70.00% - 50.00%
Operating Cash Flow Growth
-222.36% 15.76% -50.63% -42.56% -9.81% -26.77% -44.45% 46.41% 2.97% - -163.88%
Free Cash Flow Firm Growth
-216.79% 0.00% -112.85% -112.94% 0.49% 51.44% 68.90% 67.18% 25.33% - -278.74%
Invested Capital Growth
462.07% 320.71% 633.50% 1,012.02% 69.53% 1.98% 5.21% 20.25% 43.02% - 114.12%
Revenue Q/Q Growth
71.45% 40.96% -40.77% 43.19% 134.83% 35.34% 6.14% 33.53% 42.20% - 13.09%
EBITDA Q/Q Growth
24.92% -12.38% -27.97% -27.89% 55.56% -81.25% 22.33% 39.40% 50.67% - 76.89%
EBIT Q/Q Growth
9.44% -6.71% -5.90% -25.32% 12.98% -4.49% 17.75% 29.55% 31.13% - 73.75%
NOPAT Q/Q Growth
9.44% -6.71% -5.90% -25.32% 12.98% -4.49% 17.75% 29.55% 31.13% - 73.75%
Net Income Q/Q Growth
10.12% -14.63% -1.56% -26.61% 13.32% -5.24% 17.93% 32.02% 38.90% - 79.31%
EPS Q/Q Growth
9.09% -10.00% 0.00% -18.18% 23.08% -10.00% 27.27% 37.50% 40.00% - 78.95%
Operating Cash Flow Q/Q Growth
-55.44% 44.69% -103.73% 18.61% -19.73% 36.14% -132.14% 69.81% -116.79% - -965.91%
Free Cash Flow Firm Q/Q Growth
-108.22% -5.86% -44.19% -3.12% 36.78% 48.34% 7.64% -8.82% -43.81% - -76.51%
Invested Capital Q/Q Growth
635.71% 13.58% 48.80% -10.57% 12.16% -31.67% 53.52% 2.21% 33.40% - 252.52%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
-151.82% -98.35% -190.28% -195.25% -64.94% -21.19% -20.92% 8.89% 15.49% - 20.11%
EBITDA Margin
-256.97% -204.87% -398.20% -355.64% -67.29% -90.12% -65.95% -29.93% -10.38% - -18.60%
Operating Margin
-326.34% -247.06% -441.74% -386.61% -143.26% -110.60% -85.71% -45.22% -21.90% - -23.43%
EBIT Margin
-326.34% -247.06% -441.74% -386.61% -143.26% -110.60% -85.71% -45.22% -21.90% - -23.43%
Profit (Net Income) Margin
-303.50% -246.81% -423.20% -374.20% -138.13% -107.40% -83.05% -42.28% -18.16% - -17.68%
Tax Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Interest Burden Percent
93.00% 99.90% 95.80% 96.79% 96.42% 97.11% 96.90% 93.50% 82.95% - 75.46%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Return on Invested Capital (ROIC)
-185.18% -180.21% -279.02% -330.22% -105.24% -131.97% -92.69% -68.98% -35.17% - -42.89%
ROIC Less NNEP Spread (ROIC-NNEP)
-181.88% -175.16% -273.86% -324.00% -98.51% -125.65% -86.74% -65.80% -34.04% - -42.23%
Return on Net Nonoperating Assets (RNNOA)
163.20% 152.25% 222.66% 273.95% 71.56% 98.09% 58.21% 46.70% 23.15% - 26.02%
Return on Equity (ROE)
-21.98% -27.96% -56.36% -56.27% -33.68% -33.88% -34.48% -22.28% -12.01% - -16.87%
Cash Return on Invested Capital (CROIC)
0.00% -435.06% -383.65% -456.64% -237.54% -230.37% -154.05% -152.77% -125.95% - -161.20%
Operating Return on Assets (OROA)
-22.25% -23.43% -50.16% -48.17% -26.25% -23.36% -25.44% -17.20% -9.81% - -16.97%
Return on Assets (ROA)
-20.69% -23.41% -48.06% -46.63% -25.31% -22.68% -24.65% -16.08% -8.14% - -12.81%
Return on Common Equity (ROCE)
-21.98% -27.96% -56.36% -56.27% -33.68% -33.88% -34.48% -22.28% -12.01% - -16.87%
Return on Equity Simple (ROE_SIMPLE)
-50.33% 0.00% -62.67% -62.38% -76.76% 0.00% -62.73% 0.00% 0.00% - 0.00%
Net Operating Profit after Tax (NOPAT)
-6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18 -4.68
NOPAT Margin
-228.44% -172.94% -309.22% -270.62% -100.28% -77.42% -59.99% -31.65% -15.33% - -16.40%
Net Nonoperating Expense Percent (NNEP)
-3.30% -5.05% -5.16% -6.22% -6.72% -6.32% -5.95% -3.18% -1.12% - -0.66%
Return On Investment Capital (ROIC_SIMPLE)
- -11.41% - - - -11.85% -9.62% -6.22% -3.18% -17.17% -4.28%
Cost of Revenue to Revenue
251.82% 198.35% 290.28% 295.25% 164.94% 121.19% 120.92% 91.11% 84.51% - 79.89%
SG&A Expenses to Revenue
145.39% 116.00% 183.78% 141.67% 55.19% 50.41% 47.03% 39.76% 25.67% - 30.24%
R&D to Revenue
29.13% 32.71% 67.68% 49.69% 23.13% 21.48% 17.75% 14.35% 11.71% - 13.31%
Operating Expenses to Revenue
174.52% 148.71% 251.46% 191.36% 78.32% 89.41% 64.78% 54.11% 37.38% - 43.55%
Earnings before Interest and Taxes (EBIT)
-9.13 -9.74 -10 -13 -11 -12 -9.67 -6.81 -4.69 -25 -6.69
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-7.19 -8.08 -9.30 -12 -5.29 -9.58 -7.44 -4.51 -2.23 -23 -5.31
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
6.22 7.82 4.05 1.84 2.20 4.27 4.49 6.62 12.75 - 21.11
Price to Tangible Book Value (P/TBV)
6.22 7.82 4.05 1.84 2.20 4.27 4.49 6.62 12.75 - 21.11
Price to Revenue (P/Rev)
69.30 51.65 22.66 9.66 7.05 12.26 9.54 11.32 22.53 - 25.59
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Enterprise Value to Invested Capital (EV/IC)
28.77 30.05 9.75 3.94 4.21 16.85 12.18 20.18 41.46 - 47.76
Enterprise Value to Revenue (EV/Rev)
60.25 46.60 19.02 5.92 5.05 9.98 8.08 10.11 21.27 - 24.90
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Financial Leverage
-0.90 -0.87 -0.81 -0.85 -0.73 -0.78 -0.67 -0.71 -0.68 - -0.62
Leverage Ratio
1.22 1.44 1.49 1.51 1.57 1.77 1.71 1.66 1.64 - 1.39
Compound Leverage Factor
1.14 1.44 1.42 1.46 1.51 1.72 1.66 1.56 1.36 - 1.05
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Common Equity to Total Capital
100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% - 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Altman Z-Score
10.20 4.37 1.58 -0.22 -0.48 1.82 2.31 5.17 14.05 - 63.89
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.42 3.75 4.67 4.14 3.46 4.00 4.74 5.95 6.65 - 7.13
Quick Ratio
3.98 3.49 4.15 3.76 3.05 3.53 4.21 5.38 5.93 - 6.11
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-17 -18 -25 -26 -16 -8.51 -7.86 -8.55 -12 -17 -30
Operating Cash Flow to CapEx
-97.17% -83.46% -251.00% -495.89% -714.85% 0.00% -1,547.21% -595.67% -2,233.33% - -5,964.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.07 0.09 0.11 0.12 0.18 0.21 0.30 0.38 0.45 - 0.72
Accounts Receivable Turnover
4.42 9.28 10.73 8.66 5.40 7.06 5.59 7.17 4.41 - 3.95
Inventory Turnover
37.25 38.58 30.90 31.06 23.76 11.64 20.31 18.15 15.90 - 12.07
Fixed Asset Turnover
0.58 0.70 0.77 0.81 0.86 1.23 1.62 2.18 2.90 - 6.29
Accounts Payable Turnover
2.62 3.75 5.21 4.07 4.08 4.01 7.07 6.83 5.49 - 7.18
Days Sales Outstanding (DSO)
82.54 39.33 34.03 42.13 67.62 51.69 65.24 50.90 82.82 - 92.31
Days Inventory Outstanding (DIO)
9.80 9.46 11.81 11.75 15.36 31.37 17.97 20.10 22.96 - 30.25
Days Payable Outstanding (DPO)
139.07 97.45 70.12 89.71 89.49 91.00 51.65 53.41 66.49 - 50.87
Cash Conversion Cycle (CCC)
-46.73 -48.66 -24.28 -35.83 -6.51 -7.95 31.57 17.59 39.29 - 71.69
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
12 14 21 19 21 14 22 22 30 13 47
Invested Capital Turnover
0.81 1.04 0.90 1.22 1.05 1.70 1.54 2.18 2.29 - 2.61
Increase / (Decrease) in Invested Capital
10 11 18 17 8.59 0.28 1.09 3.78 9.01 -0.97 25
Enterprise Value (EV)
356 422 204 74 88 241 268 453 1,243 - 2,248
Market Capitalization
409 468 243 120 123 296 316 507 1,316 - 2,310
Book Value per Share
$0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80 $0.80
Tangible Book Value per Share
$0.76 $0.68 $0.65 $0.69 $0.50 $0.66 $0.60 $0.64 $0.83 $0.80 $0.80
Total Capital
66 60 60 65 56 69 70 77 103 104 109
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-53 -46 -39 -46 -35 -55 -48 -54 -73 -90 -62
Capital Expenditures (CapEx)
8.93 5.75 3.90 1.61 1.33 -3.63 0.91 0.72 0.41 2.36 0.63
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-5.88 -8.70 -3.18 -6.23 -3.11 -3.60 3.75 5.59 17 18 36
Debt-free Net Working Capital (DFNWC)
48 37 36 40 32 52 52 60 91 109 98
Net Working Capital (NWC)
48 37 36 40 32 52 52 60 91 109 98
Net Nonoperating Expense (NNE)
2.10 2.91 2.66 3.46 2.97 3.19 2.60 1.60 0.61 6.56 0.37
Net Nonoperating Obligations (NNO)
-53 -46 -39 -46 -35 -55 -48 -54 -73 -90 -62
Total Depreciation and Amortization (D&A)
1.94 1.66 1.02 1.04 5.97 2.18 2.23 2.30 2.47 2.51 1.38
Debt-free, Cash-free Net Working Capital to Revenue
-99.59% -96.06% -29.73% -50.15% -17.76% -14.90% 11.31% 12.46% 29.84% - 39.46%
Debt-free Net Working Capital to Revenue
805.27% 409.42% 334.84% 323.73% 182.72% 213.32% 157.52% 133.32% 155.20% - 108.54%
Net Working Capital to Revenue
805.27% 409.42% 334.84% 323.73% 182.72% 213.32% 157.52% 133.32% 155.20% - 108.54%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Adjusted Weighted Average Basic Shares Outstanding
86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Adjusted Diluted Earnings per Share
($0.10) ($0.11) ($0.11) ($0.13) ($0.10) ($0.11) ($0.08) ($0.05) ($0.03) ($0.19) ($0.04)
Adjusted Weighted Average Diluted Shares Outstanding
86.35M 86.20M 90.03M 97.05M 110.41M 101.87M 117.97M 121.78M 126.63M 124.64M 136.95M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
88.40M 91.60M 94.47M 111.05M 105.84M 117.93M 120.55M 125.08M 130.48M 137.02M 141.63M
Normalized Net Operating Profit after Tax (NOPAT)
-6.39 -6.82 -7.22 -9.05 -7.88 -8.23 -6.77 -4.77 -3.28 -18 -4.68
Normalized NOPAT Margin
-228.44% -172.94% -309.22% -270.62% -100.28% -77.42% -59.99% -31.65% -15.33% - -16.40%
Pre Tax Income Margin
-303.50% -246.81% -423.20% -374.20% -138.13% -107.40% -83.05% -42.28% -18.16% - -17.68%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 - 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% - 0.00%
Augmented Payout Ratio
-2.14% -1.63% -0.89% -1.39% -2.21% -1.69% 0.00% -1.42% 0.00% - 0.00%

Financials Breakdown Chart

Key Financial Trends

Amprius Technologies (NYSE: AMPX) showed clear top-line growth in Q1 2026, but the business is still operating at a meaningful loss and burning cash. Revenue rose to $28.5 million from $25.2 million in Q4 2025 and $11.3 million in Q1 2025, showing solid year-over-year improvement. However, gross profit remained modest relative to operating costs, and the company posted a net loss of $5.0 million for the quarter.

From a profitability standpoint, Amprius is making progress on revenue, but it has not yet translated that growth into positive operating leverage. Operating expenses totaled $12.4 million in Q1 2026, well above gross profit of $5.7 million, leading to an operating loss of $6.7 million. That is an improvement from the much larger operating loss in Q4 2025, but the company remains far from break-even.

Cash flow remains a key issue. Operating cash flow was negative $37.4 million in Q1 2026, a sharp deterioration from negative $3.5 million in Q4 2025 and worse than the already weak levels seen in prior periods. The company did, however, end the quarter with $62.4 million in cash and equivalents, which provides some near-term cushion. Still, the negative operating cash flow suggests ongoing reliance on external financing or balance sheet liquidity.

The balance sheet looks manageable for now, but leverage and working capital trends deserve attention. Total assets were $130.8 million, total liabilities were $21.4 million, and total common equity stood at $109.4 million. Current assets of $114.0 million comfortably exceeded current liabilities of $16.0 million, which is a positive sign for short-term liquidity.

Over the last several years, the overall trend is one of rapid revenue growth paired with persistent losses and heavy cash consumption. AMPX has scaled revenue from just $679 thousand in Q1 2023 to $28.5 million in Q1 2026, but operating discipline has not kept pace. Investors should view the story as one of improving commercial traction, but still early-stage economics.

  • Revenue growth remains strong, with Q1 2026 sales up meaningfully year over year and sequentially.
  • Gross profit improved to $5.7 million, indicating better unit economics than earlier periods.
  • Cash and equivalents of $62.4 million give the company some runway.
  • Current assets exceeded current liabilities, suggesting short-term liquidity is still intact.
  • Operating expenses remain high at $12.4 million, limiting progress toward profitability.
  • Share count remains elevated versus earlier periods, which can pressure per-share results.
  • Capital spending was modest in Q1 2026 at $1.0 million, so investment intensity was not especially heavy this quarter.
  • Operating cash flow was deeply negative at $37.4 million, a major concern.
  • The company posted a net loss of $5.0 million despite higher revenue.
  • Amprius still relies on financing, as cash generation from operations is not yet covering the business.

Bottom line: AMPX is showing real sales momentum, but investors should remember that this is still a cash-burning growth story. The most important question is whether revenue can keep rising fast enough to absorb operating costs and move the company toward sustainable profitability before liquidity becomes tighter.

06/15/26 10:59 PM ETAI Generated. May Contain Errors.

Amprius Technologies Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Amprius Technologies' financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Amprius Technologies' net income appears to be on an upward trend, with a most recent value of -$44.02 million in 2025, rising from -$9.90 million in 2021. The previous period was -$44.67 million in 2024. See Amprius Technologies' forecast for analyst expectations on what's next for the company.

Amprius Technologies' total operating income in 2025 was -$46.65 million, based on the following breakdown:
  • Total Gross Profit: $8.26 million
  • Total Operating Expenses: $54.91 million

Over the last 4 years, Amprius Technologies' total revenue changed from $2.77 million in 2021 to $73.01 million in 2025, a change of 2,533.9%.

Amprius Technologies' total liabilities were at $53.08 million at the end of 2025, a 2.8% increase from 2024, and a 1,036.8% increase since 2021.

In the past 4 years, Amprius Technologies' cash and equivalents has ranged from $11.49 million in 2021 to $90.47 million in 2025, and is currently $90.47 million as of their latest financial filing in 2025.

Over the last 4 years, Amprius Technologies' book value per share changed from 0.21 in 2021 to 0.80 in 2025, a change of 277.6%.



Financial statements for NYSE:AMPX last updated on 5/12/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners